OVERVIEW
The market for humanized rat models is expected to reach USD 14.3 million by 2024, increasing at a CAGR of 8.4% during the forecast period. The key factors driving market growth are the increasing number of research activities involving humanized models, increasing demand for personalized medicine, increasing the number of research and development activities in pharmaceutical and biotechnology companies, and continuous support in the form of government and private sector investments and grants.
TABLE OF CONTENT
1 Global Humanized Mouse and Rat Model MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Humanized Mouse and Rat Model Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Humanized Mouse and Rat Model Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Humanized Mouse and Rat Model Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Humanized Mouse and Rat Model Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Humanized Mouse and Rat Model Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Humanized Mouse and Rat Model Market – By Types (Market Size – & million/billion)
8.1 Humanized Mouse Models
8.2 Humanized Rat Models
9 Global Humanized Mouse and Rat Model Market – By Application
9.1 Oncology
9.2 Immunology and Infectious Diseases
9.3 Neuroscience
9.4 Toxicology
9.5 Hematopoiesis
9.6 Other
10 Global Humanized Mouse and Rat Model Market – By End-User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Contract Research Organizations
10.3 Academic & Research Institutions
11 Global Humanized Mouse and Rat Model Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Humanized Mouse and Rat Model Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Humanized Mouse and Rat Model Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 The Jackson Laboratory
13.3 Taconic Biosciences
13.4 Crown Bioscience (Subsidiary of Jsr Corporation)
13.5 Vitalstar Biotechnology
13.6 Ingenious Targeting Laboratory
13.7 Axenis
13.8 Champions Oncology
13.9 Hera Biolabs
13.10 Genoway
13.11 Horizon Discovery (Sage Labs)
13.12 Company 11 & more
14 Global Humanized Mouse and Rat Model Market – Appendix
14.1 Sources
14.2 Abbreviations
